Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Albemarle, a global developer, manufacturer and marketer of specialty chemicals for pharmaceuticals, has reported net sales of $580.27m for the first quarter ended March 31, 2010, an increase of 19.3%, compared to $486.59m for the comparable period in 2009.
Subscribe to our email newsletter
Albemarle has posted a net income of $64.91m for the first quarter 2010, or $0.69 per diluted share, compared to $26.94m, or $0.28 per diluted share, for the prior year period. Operating income was $76.26m, compared to $28.92m for the year ago period.
Mark Rohr, chairman and CEO of Albemarle, said: “We achieved strong operating results and significantly improved year over year performance across our segments including record profitability for the Corporation and in our Catalysts and Polymer Solutions businesses.
“We benefited from improving trends in the markets served by our businesses and continued our keen focus on cost control and cash generation. Our disciplined efforts toward cost control, working capital and operating efficiency have positioned us well to post record results in 2010.”